Amoxycillin + Potassium Clavulanate Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 500 mg/125 mg, 875 mg/125 mg, 2 g/125 mg
Reference Brands: Augmentin, Augmentin XR(US); Augmentin, Amoxiclav(EU)
Category:
Antibiotics
Amoxicillin-clavulanate inhibits bacterial cell wall synthesis via amoxicillin and overcomes beta-lactamase enzymes with clavulanate, expanding antibacterial coverage. Benefits include broad-spectrum activity, effectiveness against resistant bacteria, rapid infection control, and use in respiratory, urinary, skin, and soft tissue infections, offering reliable, combination therapy when prescribed appropriately.
Amoxycillin + Potassium Clavulanate Tablets is available in Tablets
and strengths such as 500 mg/125 mg, 875 mg/125 mg, 2 g/125 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Amoxycillin + Potassium Clavulanate Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Amoxycillin + Potassium Clavulanate Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Amoxicillin Potassium + Clavulanate tablets are approved in both EU and US for treating bacterial infections. In the EU, brands like Augmentin are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on extensive clinical data; generics are also available. Both regions require detailed dossiers, including clinical trial results and pharmacovigilance plans, for initial approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for amoxicillin-clavulanate tablets, ensuring adherence to European and US standards for safe, effective antibacterial therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing